Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization

Dihan Zhou1, Yan Zhang, Qiaoli Li

  • 1Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.

Journal of Virology
|August 26, 2011
PubMed

Insights

Measles virus (MV) matrix protein-specific IgA antibodies can block viral replication through intracellular neutralization. This suggests the M protein is a viable target for future MV vaccine development.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Measles virus (MV) remains a significant public health concern.
  • The MV matrix (M) protein is crucial for viral replication and assembly.
  • Targeting internal viral proteins with IgA antibodies is a potential strategy for mucosal immunity.

Purpose of the Study:

  • To investigate the efficacy of an M protein-specific IgA monoclonal antibody (5H7) in inhibiting MV replication and assembly.
  • To explore the potential of the M protein as a target antigen for MV vaccines.

Main Methods:

  • Generation of a panel of monoclonal antibodies against MV M protein, including an IgA MAb (5H7).
  • Utilized polarized Vero cells in a transwell model to assess IgA MAb activity.
  • Investigated viral replication, assembly, and intracellular neutralization via colocalization studies.

Main Results:

  • The M-specific IgA MAb (5H7) inhibited MV replication by 78% through intracellular neutralization.
  • The antibody did not exhibit traditional neutralization or immune exclusion activities.
  • Colocalization confirmed direct binding of IgA MAb to intracellular M proteins.
  • MV replication demonstrated a prolonged entry and assembly phase, offering a window for IgA intervention.

Conclusions:

  • IgA antibodies targeting internal viral antigens, like the MV M protein, can provide mucosal immune protection via intracellular neutralization.
  • The MV M protein is an effective target antigen for therapeutic or vaccine strategies.
  • Future MV vaccine design could incorporate the M protein to elicit protective IgA responses.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...